British Columbia researchers want to use psychedelics to treat addiction
published on April 21, 2017 by Matt Kieltyka in Metro News
The B.C. Centre on Substance Use is seeking funding to start clinical trials using psychedelic drugs in a therapy setting to treat addiction.
The use of psychedelic drugs for therapy pretty much ended in Canada in the 1960s but British Columbia researchers want to bring the far-out treatment back in the midst of the province’s fentanyl-fuelled overdose crisis.
The B.C. Centre on Substance Use – set up by the provincial government in response to the public health emergency – announced Friday it is seeking funding to begin clinical trials studying the use of psychedelics as a treatment option for addictions.
BCCSU director Dr. Kenneth Tupper said Canada was once a world-leader in the field of psychedelics until street use of drugs like LSD became a problem in the 60s and government made them illegal even in clinical settings.
“Research was shut down for several decades,” said Tupper, currently attending the international Psychedelic Science 2017 conference in Oakland, California. “But in the last decade, really the last five years, there’s been a wave of new studies in other parts of the world. The BCCSU would like to get Canada back in the cutting edge of medicine.”
The latest studies on psychedelic-assisted therapies have been promising, according to Tupper.
The U.S.’s John Hopkins School of Medicine ran a pilot program using psychedelic-assisted therapy for people with tobacco dependency and had an 80 per cent success rate treating the addiction after six months.